Want to see NUTX full AI Analyst Report?
Clinigence Holdings (NUTX) Ratios
Clinigence Holdings Ratios
NUTX's free cash flow for Q2 2026 was $31.66M. For the 2026 fiscal year, NUTX's free cash flow was decreased by $-2.54M and operating cash flow was $34.20M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.41 | 2.08 | 1.56 | 1.79 | 4.09 |
| Quick Ratio | 3.39 | 2.06 | 1.50 | 1.72 | 4.01 |
| Cash Ratio | 1.18 | 0.31 | 0.38 | 0.62 | 0.96 |
| Solvency Ratio | 0.18 | 0.16 | -0.09 | -1.32 | 0.69 |
| Operating Cash Flow Ratio | 1.57 | 0.16 | 0.02 | 0.92 | 4.60 |
| Short-Term Operating Cash Flow Coverage | 17.63 | 1.29 | 0.09 | 3.34 | 16.95 |
| Net Current Asset Value | $ 43.72M | $ -160.95M | $ -228.29M | $ -213.45M | $ -49.05M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.38 | 0.52 | 0.69 | 0.62 | 0.45 |
| Debt-to-Equity Ratio | 1.07 | 2.33 | 4.49 | 2.79 | 1.56 |
| Debt-to-Capital Ratio | 0.52 | 0.70 | 0.82 | 0.74 | 0.61 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.13 | 0.30 | 0.19 | 0.41 |
| Financial Leverage Ratio | 2.79 | 4.48 | 6.48 | 4.50 | 3.44 |
| Debt Service Coverage Ratio | 6.15 | 3.54 | -0.31 | -14.72 | 11.11 |
| Interest Coverage Ratio | 12.40 | 6.55 | -1.95 | -32.55 | 27.48 |
| Debt to Market Cap | 0.04 | 0.25 | 0.34 | 0.03 | 0.00 |
| Interest Debt Per Share | 58.73 | 70.63 | 66.26 | 66.17 | 45.98 |
| Net Debt to EBITDA | 0.58 | 2.00 | -17.40 | -0.59 | 0.78 |
| Profitability Margins | |||||
| Gross Profit Margin | 50.76% | 40.89% | 14.04% | 7.03% | 54.08% |
| EBIT Margin | 30.51% | 27.02% | -12.99% | -185.67% | 52.99% |
| EBITDA Margin | 32.85% | 30.97% | -5.89% | -179.68% | 55.33% |
| Operating Profit Margin | 31.49% | 27.22% | -12.83% | -185.41% | 51.36% |
| Pretax Profit Margin | 27.97% | 22.87% | -19.58% | -191.36% | 51.12% |
| Net Profit Margin | 8.09% | 10.87% | -18.49% | -193.70% | 39.99% |
| Continuous Operations Profit Margin | 20.61% | 19.85% | -17.53% | -197.33% | 50.83% |
| Net Income Per EBT | 28.92% | 47.54% | 94.42% | 101.22% | 78.23% |
| EBT Per EBIT | 88.81% | 84.02% | 152.61% | 103.21% | 99.55% |
| Return on Assets (ROA) | 7.71% | 7.96% | -11.50% | -98.39% | 33.60% |
| Return on Equity (ROE) | 21.49% | 35.65% | -74.51% | -443.11% | 115.65% |
| Return on Capital Employed (ROCE) | 36.24% | 25.39% | -9.35% | -107.88% | 47.70% |
| Return on Invested Capital (ROIC) | 25.91% | 20.91% | -7.90% | -102.17% | 45.74% |
| Return on Tangible Assets | 8.01% | 8.34% | -12.69% | -107.94% | 33.75% |
| Earnings Yield | 6.76% | 32.29% | -38.47% | -35.26% | 0.55% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.69 | 2.03 | 3.94 | 3.76 | 2.89 |
| Payables Turnover | 8.80 | 20.32 | 8.42 | 8.52 | 8.62 |
| Inventory Turnover | 150.38 | 99.55 | 62.78 | 57.70 | 54.10 |
| Fixed Asset Turnover | 2.55 | 1.48 | 0.92 | 0.74 | 1.39 |
| Asset Turnover | 0.95 | 0.73 | 0.62 | 0.51 | 0.84 |
| Working Capital Turnover Ratio | 3.29 | 5.21 | 6.55 | 2.75 | 3.01 |
| Cash Conversion Cycle | 96.66 | 165.22 | 54.99 | 60.55 | 90.77 |
| Days of Sales Outstanding | 135.71 | 179.52 | 92.52 | 97.06 | 126.34 |
| Days of Inventory Outstanding | 2.43 | 3.67 | 5.81 | 6.33 | 6.75 |
| Days of Payables Outstanding | 41.47 | 17.96 | 43.35 | 42.84 | 42.32 |
| Operating Cycle | 138.13 | 183.18 | 98.34 | 103.39 | 133.09 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 39.00 | 4.54 | 0.29 | 11.97 | 43.16 |
| Free Cash Flow Per Share | 38.61 | 4.09 | -1.87 | 8.51 | 33.97 |
| Dividend Paid and CapEx Coverage Ratio | 3.23 | 2.65 | 0.09 | 0.77 | 0.96 |
| Capital Expenditure Coverage Ratio | 98.23 | 10.05 | 0.13 | 3.46 | 4.70 |
| Operating Cash Flow Coverage Ratio | 0.71 | 0.07 | 0.00 | 0.19 | 0.97 |
| Operating Cash Flow to Sales Ratio | 0.28 | 0.05 | 0.01 | 0.23 | 0.52 |
| Free Cash Flow Yield | 23.45% | 12.90% | -6.92% | 2.99% | 0.57% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.79 | 3.10 | -2.60 | -2.84 | 181.82 |
| Price-to-Sales (P/S) Ratio | 1.20 | 0.34 | 0.48 | 5.49 | 72.72 |
| Price-to-Book (P/B) Ratio | 3.18 | 1.10 | 1.94 | 12.57 | 210.27 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 4.26 | 7.75 | -14.44 | 33.48 | 176.61 |
| Price-to-Operating Cash Flow Ratio | 4.22 | 6.98 | 94.73 | 23.80 | 139.00 |
| Price-to-Earnings Growth (PEG) Ratio | 1.68 | -0.02 | 0.03 | 0.01 | 5.07 |
| Enterprise Value Multiple | 4.22 | 3.08 | -25.57 | -3.65 | 132.19 |
| Enterprise Value | 1.21B | 458.34M | 372.78M | 1.44B | 24.25B |
| EV to EBITDA | 4.22 | 3.08 | -25.57 | -3.65 | 132.19 |
| EV to Sales | 1.39 | 0.95 | 1.51 | 6.56 | 73.15 |
| EV to Free Cash Flow | 4.94 | 21.98 | -45.24 | 39.96 | 177.65 |
| EV to Operating Cash Flow | 4.89 | 19.80 | 296.69 | 28.41 | 139.83 |
| Tangible Book Value Per Share | 61.04 | 33.81 | 9.42 | 19.43 | 47.23 |
| Shareholders’ Equity Per Share | 51.79 | 28.69 | 13.94 | 22.68 | 28.53 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.13 | 0.10 | -0.03 | 0.01 |
| Revenue Per Share | 137.59 | 94.11 | 56.18 | 51.88 | 82.51 |
| Net Income Per Share | 11.13 | 10.23 | -10.39 | -100.50 | 33.00 |
| Tax Burden | 0.29 | 0.48 | 0.94 | 1.01 | 0.78 |
| Interest Burden | 0.92 | 0.85 | 1.51 | 1.03 | 0.96 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.19 | 0.12 | 0.13 | 0.09 | 0.02 |
| Stock-Based Compensation to Revenue | 0.13 | 0.03 | 0.01 | 0.00 | 0.00 |
| Income Quality | 1.38 | 0.24 | -0.03 | -0.12 | 1.03 |
Currency in USD
